Coopers Actionable Tips Request a full panel for metabolic health: ask your provider about fasting insulin, GIR, HbA1c, lipids, and FIB-4even if you havent been flagged as at risk
However, with liraglutides patents expiring, cheaper generics will likely be available in 2024, which could see its use expand again.
Recent phase 2 trials show unprecedented weight loss, improved glycemic control, favorable changes in fat mass and liver fat, and a promising safety profile
Nevertheless, emerging clinical data suggest that these agents may exert beneficial effects on testosterone levels in men, potentially mediated by improved insulin sensitivity and reductions in adiposity
of obesity discrimination, shutting down an attempt to broaden coverage of blockbuster GLP-1 weight-loss drugs